The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. GlycoMimetics Inc shares valued at $30,716 were purchased by Rock Edwin on Jun 21 ’24. At $0.27 per share, Rock Edwin acquired 115,000 shares. The insider’s holdings grew to 680,403 shares worth approximately $0.22 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Rock Edwin purchased 190,000 shares, netting a total of over 48,108 in proceeds. Following the buying of shares at $0.25 each, the insider now holds 565,403 shares.
Before that, Hahn Brian M. had added 17,500 shares to its account. In a trade valued at $4,335, the SVP Finance, CFO bought GlycoMimetics Inc shares for $0.25 each. Upon closing the transaction, the insider’s holdings increased to 17,500 shares, worth approximately $22605.760000000002.
As published in their initiating research note from CapitalOne on December 22, 2023, GlycoMimetics Inc [GLYC] has been an Overweight and the price target has been revised to $12. Analysts at Jefferies upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid November. As of November 14, 2019, ROTH Capital has initiated its “Buy” rating for GLYC. Earlier on August 05, 2019, SunTrust downgraded its rating. Their new recommendation was “a Hold” for GLYC stock which previously was a “a Buy”.
Analyzing GLYC Stock Performance
During the last five days, there has been a surge of approximately 26.88%. Over the course of the year, GlycoMimetics Inc shares have dropped approximately -86.56%. Shares of the company reached a 52-week high of $3.5299 on 01/23/24 and a 52-week low of $0.2350 on 06/20/24. A 50-day SMA is recorded $0.6786, while a 200-day SMA reached $1.8272. Nevertheless, trading volume fell to 4.21 million shares from 8.56 million shares the previous day.
Support And Resistance Levels for GlycoMimetics Inc (GLYC)
According to the 24-hour chart, there is a support level at 0.2831, which, if violated, would cause prices to drop to 0.2491. In the upper region, resistance lies at 0.3356. The next price resistance is at 0.3541. RSI (Relative Strength Index) is 40.35 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0447, which suggests the price will decrease in the coming days. Percent R is at 59.51%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
